相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles
H. S. Sader et al.
JOURNAL OF CHEMOTHERAPY (2007)
Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients
N Simon et al.
CLINICAL PHARMACOKINETICS (2006)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Experience with a once-daily dosing program of aminoglycosides in critically ill patients
SE Buijk et al.
INTENSIVE CARE MEDICINE (2002)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Bactericidal activity of bound ceftriaxone against Streptococcus pneumoniae
H Elkhaili et al.
MEDECINE ET MALADIES INFECTIEUSES (2001)
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
GM Joynt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Sensitive assay for the determination of cefazolin or ceftriaxone in plasma utilizing LC
S Al-Rawithi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)